Yueh-Chu Wu

Yueh-Chu Wu

Auto-generated profile, based on publicly available information

Yueh-Chu Wu

Department of Nursing, Diabetes Education Center, Chung Shan Medical University Hospital, Taichung, Taiwan

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2025 in Journal of Diabetes Investigation
Verified
Journal Article
Open access
YWYueh‐Chu Wu
Yueh‐Chu Wu
MMMan‐Ting Mao
Man‐Ting Mao
HHHung‐En Huang
Hung‐En Huang
CHChien‐Ning Huang
Chien‐Ning Huang
WLWen-Chun LIAO
Wen-Chun LIAO
Aims/Introduction: Middle‐aged and elderly individuals in Asia with type 2 diabetes mellitus have an increased risk of developing sarcopenia. This systematic review and meta‐analysis aimed to estimate sarcopenia prevalence and identify key risk factors among middle‐aged and elderly type 2 diabetes mellitus persons in Asia. Materials and Methods: We searched PubMed , Embase, Cochrane Library, Web of Science, and CINAHL up to August 2025. Observational studies on persons aged ≥45 with type 2 diabetes mellitus reporting sarcopenia prevalence and risk factors were included. Quality was assessed using the Newcastle–Ottawa Scale, and random‐effects models calculated pooled estimates. Results: A total of 43 studies with sarcopenia prevalence in type 2 diabetes mellitus ranging from 4.0% to 50.0% were included. The pooled prevalence among individuals with type 2 diabetes mellitus was 17 (14–21%), 13 (8–18%), and 17% (14–21%) for overall, middle‐aged, and elderly individuals, respectively, with no significant difference between the middle‐aged and elderly individuals. Sarcopenia was higher in Southeast Asia (28%). Key risk factors included advanced age ( OR = 1.12), elevated HbA 1c ( OR = 1.11), diabetes‐related complications (nephropathy OR = 1.76 and neuropathy OR = 3.28), and a higher body fat percentage in men ( OR = 1.26) and women ( OR = 1.27). In contrast, protective factors included a higher BMI ( OR = 0.66), a better Mini Nutritional Assessment score ( OR = 0.37), and the use of metformin ( OR = 0.26). Conclusions: Sarcopenia is common in middle‐aged and older Asian adults with type 2 diabetes mellitus. Interventions targeting glycemic control, complications, body composition, nutrition, and metformin may help reduce risk. This study highlights the importance of early sarcopenia screening and prevention, especially in middle‐aged individuals with type 2 diabetes mellitus. Further studies are needed to establish causal relationships for prevention.

13 July 2026 in Acta Diabetologica
Verified
Journal Article
Open access
YWYueh-Chu Wu
Yueh-Chu Wu
LLLi-Na Liao
Li-Na Liao
YLYu-Fen Lai
Yu-Fen Lai
HHHung-En Huang
Hung-En Huang
WLWen-Chun LIAO
Wen-Chun LIAO
CHChien-Ning Huang
Chien-Ning Huang
This randomized controlled trial examined whether benefits achieved during supervised resistance training (SRT) were sustained after transitioning to self-managed home-based training in older adults with type 2 diabetes mellitus (T2DM) and sarcopenia. In this single-center, parallel-group trial, adults aged ≥ 65 years with T2DM and sarcopenia were randomized 1:1 to a 24-week resistance-training intervention or control. The intervention comprised 12 weeks of SRT followed by 12 weeks of self-managed home-based training. Co-primary outcomes were skeletal muscle index (SMI), handgrip strength (HGS), five-times-sit-to-stand (5TSTS), and SARC-CalF score. Secondary outcomes were HbA1c and SF-12 physical and mental component summary scores. Longitudinal changes were evaluated using generalized estimating equations. Sixty-two participants were randomized (median age, 72 years; 67.7% female). At 12 weeks, SRT significantly improved HGS, 5TSTS performance, and SARC-CalF score, whereas SMI showed no significant between-group difference. At 24 weeks, SMI showed a modest favorable change, but earlier improvements in HGS, 5TSTS performance, and SARC-CalF score were attenuated after transition to self-managed training. SF-12 scores showed supportive, favorable patterns through 24 weeks, whereas HbA1c showed no clear intervention-related change. In older adults with T2DM and sarcopenia, transition from SRT to self-managed home-based training produced outcome-specific effects. Functional gains diminished after supervision ended, whereas SMI showed a modest, delayed, favorable change. These findings suggest that hybrid support models incorporating periodic supervision, remote monitoring, automated reminders, and feedback-guided exercise logs may be needed to sustain adherence, exercise quality, and functional capacity. Retrospectively registered at ClinicalTrials.gov (NCT07398495), February 23, 2026.